Hortobagyi, Gabriel N <br/><br/>
Ribociclib for HR-Positive, Advanced Breast Cancer.  [electronic resource] 

 -  The New England journal of medicine  01 2017 
 - 289 p.  digital 
<br/><br/> Publication Type: Letter; Comment 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMc1615255  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast<br/>Breast Neoplasms<br/>Humans<br/>Receptor, ErbB-2<br/>Receptors, Estrogen